What actually happens when you quit Ozempic? New study sheds light READ MORE: The battle to keep the weight off after Ozempic, patients explain By CASSIDY MORRISON SENIOR HEALTH REPORTER FOR DAILYMAIL.COM Published: 16:50 EST, 13 November 2024 | Updated: 16:52 EST, 13 November 2024 e-mail View comments People who stop taking the weight-loss drugs Ozempic and Wegovy are likely to face serious health problems. A new study found a majority of people who stopped taking semaglutide, the active ingredient in the blockbuster drugs, regained about two-thirds of the weight lost and had worsening health markers, including higher blood pressure and cholesterol and increased risk of heart disease.
Wegovy and Ozempic are known as GLP-1 receptor agonists and lead to weight loss by mimicking the actions of GLP-1, a hormone in the brain that regulates appetite and feelings of fullness. Approximately 12 percent of US adults report having ever used a GLP-1 receptor agonist, while six percent indicated they were currently using the therapy. Around 85 percent of people who had recently started medications like Ozempic discontinued use within two years, and 71 percent stopped within the first year, either because they had reached their goal weight or because the drugs are too expensive - with a price tag of approximately $1,000 monthly.
Since it exploded on the market, semaglutide has not only shown success in treating diabetes and obesity, but new research shows it also has great promise in lowe.
